Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8338431 Phosphodiesterase inhibitors

Patent 8338431 was granted and assigned to Leo Pharma on December, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Leo Pharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

83384310

Patent Inventor Names

Ravindra Babu Bollu0

Jakob Felding0

Jens Christian Højland Larsen0

Simon Feldbæk Nielsen0

Date of Patent

December 25, 2012

Patent Application Number

125286490

Date Filed

February 26, 2008

Patent Citations Received

‌

US Patent 11981681 Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors

‌

US Patent 12084457 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Patent Primary Examiner

‌

Yong Chu

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8338431 Phosphodiesterase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API